FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors
Key Takeaways: The Expedited Investigational New Drug (IND) Pilot Program is intended to evaluate whether leveraging qualified research institutions (QRIs) and a rolling review process can improve the efficiency of...
Knobbe Martens Named a California Powerhouse by Law360
Publication highlights firm’s across-the-board strength in intellectual property law IRVINE, Calif., September 24, 2026 – Knobbe Martens is proud to announce that it has been named among Law360’s 2026 California...
Patent, Protect, or Pause: Triaging AI-Drafted Invention Disclosures in Biopharma
Key Takeaway: As AI-drafted invention disclosures become more common, counsel are reading past the polished prose, and thinking harder about privilege, and confidentiality. If invention disclosures sound different lately, look...